Sign In
Last checked at 
30 Oct 2017 07:00
30 October 2017
Venture Life Group plc
("Venture Life" or "the Group")
UltraDEX update
Venture Life Group plc (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces it has reached an agreement for its first launch of the UltraDEX brand into the convenience store channel.
Following a successful trial at one of their sites, the UK's leading provider of motorway service stations, Moto Hospitality Ltd., will launch UltraDEX mouth spray 9ml into WH Smith stores across its 61 service station outlets, effective from 16 November 2017. The convenience store channel has not yet been exploited by UltraDEX and offers a significant opportunity to access new customers. Distribution will be managed by Albert Harrison & Co. Ltd., which specialises in delivered wholesale of health & beauty, confectionary and stationery products. This agreement paves the way for future development of this important retail channel.
Following new long term partnering agreements announced previously this year, preparations for the new territories are on track in France, Italy and the Nordics, where UltraDEX is expected to be launched in Q1 2018.
Data from recent marketing activities has shown UltraDEX continues to perform well against its competitors in the UK, and the brand now has its highest ever level of listings countrywide.
Jerry Randall, CEO of Venture Life commented: "Achieving this first step onto the extensive convenience store channel has been a significant win for UltraDEX. Moto is the leading provider of convenience stores on the UK motorway network and enjoys meaningful footfall. I am delighted with the continued commercial development of the UltraDEX brand both in the UK and internationally, with the brand preparing to launch in a number of new European markets in Q1 2018, including France and Italy."
For further information please contact:
Venture Life Group PLC | +44 (0) 1344 742870 | |||
Jerry Randall, Chief Executive Officer | ||||
Adrian Crockett, Chief Financial Officer | ||||
Northland Capital Partners Limited (Nominated Adviser and Joint Broker) | +44 (0) 20 3861 6625 | |||
Matthew Johnson / Edward Hutton (Corporate Finance) | ||||
Bob Pountney / John Howes (Corporate Broking) | ||||
Turner Pope Investments (TPI) Ltd (Joint Broker) | +44 (0) 20 3621 4120 | |||
James Pope / Ben Turner | ||||
Walbrook PR | venturelife@walbrookpr.com or + 44 (0) 20 7933 8780 | |||
Anna Dunphy / Paul McManus | +44 (0) 7876 741 001 / +44 (0) 7980 541 893 | |||
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
Follow the stocks
